DK103581A - Heterocycliske forbindelser deres fremstilling og anvendelse - Google Patents

Heterocycliske forbindelser deres fremstilling og anvendelse

Info

Publication number
DK103581A
DK103581A DK103581A DK103581A DK103581A DK 103581 A DK103581 A DK 103581A DK 103581 A DK103581 A DK 103581A DK 103581 A DK103581 A DK 103581A DK 103581 A DK103581 A DK 103581A
Authority
DK
Denmark
Prior art keywords
heterocyclic
relationships
preparation
heterocyclic relationships
Prior art date
Application number
DK103581A
Other languages
English (en)
Other versions
DK154299B (da
DK154299C (da
Inventor
G Walther
C S Schneider
K H Weber
A Fuegner
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of DK103581A publication Critical patent/DK103581A/da
Publication of DK154299B publication Critical patent/DK154299B/da
Application granted granted Critical
Publication of DK154299C publication Critical patent/DK154299C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/20—Dibenz [b, e] azepines; Hydrogenated dibenz [b, e] azepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/20—[b, f]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK103581A 1980-03-08 1981-03-06 Analogifremgangsmaade til fremstilling af dibenzoimidazo-azepiner, -oxazepiner og -thiazepiner DK154299C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3008944 1980-03-08
DE19803008944 DE3008944A1 (de) 1980-03-08 1980-03-08 Dibenzimidazoazepine, ihre herstellung und verwendung

Publications (3)

Publication Number Publication Date
DK103581A true DK103581A (da) 1981-09-09
DK154299B DK154299B (da) 1988-10-31
DK154299C DK154299C (da) 1989-03-28

Family

ID=6096617

Family Applications (1)

Application Number Title Priority Date Filing Date
DK103581A DK154299C (da) 1980-03-08 1981-03-06 Analogifremgangsmaade til fremstilling af dibenzoimidazo-azepiner, -oxazepiner og -thiazepiner

Country Status (29)

Country Link
US (1) US4313931A (da)
EP (1) EP0035749B1 (da)
JP (1) JPS56139484A (da)
AU (1) AU535359B2 (da)
BG (1) BG33886A3 (da)
CA (1) CA1150253A (da)
CS (2) CS221288B2 (da)
DD (1) DD156708A5 (da)
DE (2) DE3008944A1 (da)
DK (1) DK154299C (da)
ES (1) ES8301481A1 (da)
FI (1) FI70898C (da)
GB (1) GB2071095B (da)
GR (1) GR74805B (da)
HK (1) HK63186A (da)
HU (1) HU180628B (da)
IE (1) IE51015B1 (da)
IL (1) IL62309A (da)
MX (1) MX6869E (da)
NO (1) NO162073C (da)
NZ (1) NZ196446A (da)
PH (1) PH15839A (da)
PL (1) PL132141B1 (da)
PT (1) PT72631B (da)
RO (1) RO81652B (da)
SU (1) SU1015829A3 (da)
UA (1) UA8041A1 (da)
YU (1) YU42557B (da)
ZA (1) ZA811500B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134672A1 (de) * 1981-09-02 1983-03-17 Boehringer Ingelheim KG, 6507 Ingelheim Heterocyclische verbindungen, ihre herstellung und verwendung
JPS60500176A (ja) * 1982-12-30 1985-02-07 ビ−チヤム　グル−プ　ピ−エルシ− 四環式化合物
DE4102148A1 (de) * 1991-01-25 1992-07-30 Boehringer Ingelheim Kg Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
DE19958460A1 (de) * 1999-12-03 2001-06-07 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US20100310477A1 (en) * 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
RU2204563C2 (ru) * 2001-06-22 2003-05-20 Ярославский государственный технический университет Гетероциклические о-дикарбонитрилы
DE10152973A1 (de) * 2001-10-26 2003-05-08 Boehringer Ingelheim Int Neue trockene und wässrige Epinastin-Sirup-Formulierung
JP4298212B2 (ja) * 2002-03-29 2009-07-15 大日本印刷株式会社 塩酸エピナスチン高融点型結晶の製造法
US7196193B2 (en) * 2002-04-11 2007-03-27 Konica Minolta Chemical Co., Ltd. Method for preparing 6-aminomethyl-6, 11-dihydro-5h-dibenz[b,e]azepine
JP4514017B2 (ja) * 2003-03-27 2010-07-28 大日本印刷株式会社 塩酸エピナスチンの製造方法
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
DK2377557T3 (da) 2004-11-24 2017-02-06 Meda Pharmaceuticals Inc Sammensætninger, der omfatter azelastin, og metoder til brug deraf
JP2009500397A (ja) * 2005-07-08 2009-01-08 千寿製薬株式会社 エピナスチンを含む眼科用経皮吸収型製剤
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
KR101386530B1 (ko) 2006-12-29 2014-04-18 케이피엑스 라이프사이언스 주식회사 순도 및 수율이 향상된3-아미노-9,13ｂ디하이드로-1Ｈ-디벤즈-[ｃ,ｆ]이미다조[1,5-ａ]-아제핀 염산염의 제조방법
WO2009063504A2 (en) * 2007-09-24 2009-05-22 Usv Limited Novel crystal modification of epinastine or salts thereof and process for preparation thereof
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
JP2010120960A (ja) * 2010-02-17 2010-06-03 Dainippon Printing Co Ltd 塩酸エピナスチンの製造方法
JP6006634B2 (ja) * 2011-12-28 2016-10-12 東和薬品株式会社 イソウレア化合物を用いるエピナスチンの製造方法
CN103172638B (zh) * 2013-03-13 2015-09-16 北京朗依制药有限公司 一种盐酸依匹斯汀的制备方法
CN104098575B (zh) * 2013-04-15 2016-06-01 四川科瑞德凯华制药有限公司 一种盐酸依匹斯汀晶型及其制备方法和用途
KR102041389B1 (ko) * 2017-12-12 2019-11-27 (주)프론트바이오 N-(9,13b-디하이드로-1H-디벤조[c,f]이미다조[1,5-a]아제핀-3-일)-2-하이드록시벤즈아미드 및 2-((9,13b-디하이드로-1H-디벤조[c,f]이미다조[1,5-a]아제핀-3-일) 카바모일)페닐 아세테이트의 화합물, 이의 제조방법 및 이를 포함하는 항염증 및 진통제 조성물
KR102080239B1 (ko) 2019-08-06 2020-02-21 한양대학교 에리카산학협력단 에피나스틴의 신규 제조방법
CN115974882A (zh) * 2023-02-08 2023-04-18 广州艾格生物科技有限公司 一种盐酸依匹斯汀杂质的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE789410A (fr) * 1971-10-05 1973-01-15 Akzo Nv Nieuwe imidazolidine derivaten
NL7202963A (da) * 1972-03-07 1973-09-11
NL7414038A (nl) * 1974-10-28 1976-05-03 Akzo Nv Nieuwe tetracyclische pyrrolidino derivaten.

Also Published As

Publication number Publication date
GR74805B (da) 1984-07-12
NO810762L (no) 1981-09-09
NZ196446A (en) 1984-07-06
JPH0366311B2 (da) 1991-10-16
HU180628B (en) 1983-03-28
PL132141B1 (en) 1985-02-28
PL230036A1 (da) 1982-05-24
CS410491A3 (en) 1992-05-13
NO162073C (no) 1989-11-01
CS221288B2 (en) 1983-04-29
IE810485L (en) 1981-09-08
FI70898C (fi) 1986-10-27
ES500150A0 (es) 1982-12-01
US4313931A (en) 1982-02-02
PH15839A (en) 1983-04-08
GB2071095A (en) 1981-09-16
NO162073B (no) 1989-07-24
IL62309A0 (en) 1981-05-20
ES8301481A1 (es) 1982-12-01
FI70898B (fi) 1986-07-18
UA8041A1 (uk) 1995-12-26
EP0035749A1 (de) 1981-09-16
HK63186A (en) 1986-09-05
DD156708A5 (de) 1982-09-15
DE3008944A1 (de) 1981-09-24
BG33886A3 (en) 1983-05-16
RO81652B (ro) 1983-04-30
EP0035749B1 (de) 1984-06-06
YU42557B (en) 1988-10-31
SU1015829A3 (ru) 1983-04-30
AU535359B2 (en) 1984-03-15
PT72631A (fr) 1981-04-01
AU6815881A (en) 1981-09-17
JPS56139484A (en) 1981-10-30
FI810712L (fi) 1981-09-09
DK154299B (da) 1988-10-31
YU56881A (en) 1983-10-31
DK154299C (da) 1989-03-28
IE51015B1 (en) 1986-09-03
GB2071095B (en) 1983-06-02
IL62309A (en) 1984-06-29
ZA811500B (en) 1982-11-24
DE3163938D1 (en) 1984-07-12
CA1150253A (en) 1983-07-19
PT72631B (fr) 1982-12-30
RO81652A (ro) 1983-04-29
MX6869E (es) 1986-09-11

Similar Documents

Publication Publication Date Title
DK103581A (da) Heterocycliske forbindelser deres fremstilling og anvendelse
DK457781A (da) Bicyclooxyhenylurinstoffer deres fremstilling og anvendelse
DK374980A (da) Disazoforbindelser deres fremstilling og anvendelse
DK540280A (da) Sulfonylurinstoffer deres fremstilling og anvendelse
DK383581A (da) Aminosyrederivater deres fremtilling og anvendelse
DK283479A (da) 1-(3-mercapto-2-methylpropanoyl)-prolyl-aminosyre-derivater deres fremstilling og anvendelse
DK242578A (da) Tetrahydrofuranderivater deres fremstilling og anvendelse
NO814112L (no) 1-sulfo-2-oksoazetidinderivater og fremgangsmaate for deres fremstilling
NO813804L (no) Substituerte pyrimidiner og fremgangsmaate for deres fremstilling
DK41484A (da) Beta-phenethanolaminer og deres anvendelse
NO823083L (no) Bisestere av alkenylravsyrer og etylenoksyd-propylenoksyd-blokkpolymerisater og deres anvendelse
DK543879A (da) Monoazopigmentblandinger deres fremstilling og anvendelse
NO823084L (no) Addisjonsprodukter av trietanolaminkodensater og bis-glycidyletere og deres anvendelse
DK278178A (da) Sulfamoylarylketoner deres fremstilling og anvendelse
DK30082A (da) Kemiske forbindelser deres fremstilling og deres anvendelse i laegemidler
DK270382A (da) Depotmaterialer deres fremstilling og anvendelse
DK58581A (da) Thiolestere deres fremstilling og anvendelse
DK298881A (da) Isoxazolylimidazolidinonderivater deres fremstilling og anvendelse som herbicider
DK155380A (da) Distyrylbiphenyler deres fremstilling og anvendelse
DK169481A (da) Kobberphthalocyaninpigmenter deres fremstilling og deres anvendelse
DK581181A (da) Thiazolinderivater deres fremstilling og anvendelse
DK286480A (da) Oxinethere deres fremstilling og anvendelse
DK301680A (da) N-carboxylerede carbamater deres fremstilling og anvendelse
DK286580A (da) Thiazolinderivater deres fremstilling og anvendelse
DK318081A (da) Kondenserede as-triazinderivater deres fremstilling og anvendelse

Legal Events

Date Code Title Description
PUP Patent expired